GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Clovis Oncology Stock and on which exchange is it traded?
The symbol for Clovis Oncology is CLVS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Clovis Oncology Stock?
Clovis Oncology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Clovis Oncology Stock?
Clovis Oncology Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Clovis Oncology Stock.

What's the current price of Clovis Oncology Stock?
As of the end of day on the 2023-04-19, the price of an Clovis Oncology (CLVS) share was $0.151.

What is the 52-week high and low for Clovis Oncology Stock?
The 52-week high for Clovis Oncology Stock is $3.25 and the 52-week low is $0.0471.
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT